{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "A report on the health effects of small doses of radiation has renewed a debate on the way exposure is regulated and how the public should regard such doses. The report, issued by the National Academy of Sciences, incorporates nearly 15 years of new data on atomic bomb survivors in Japan.", "headline": {"main": "With New Data, a Debate on Low-Level Radiation"}, "abstract": null, "print_page": "6", "word_count": 984, "_id": "4fd25f0c8eb7c8105d80eb00", "snippet": "A report on the health effects of small doses of radiation has renewed a debate on the way exposure is regulated and how the public should regard such doses.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/19/science/19radi.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "RADIATION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"firstname": "Matthew", "middlename": "L.", "lastname": "WALD", "rank": 1, "role": "reported", "organization": ""}], "original": "By MATTHEW L. WALD"}, "document_type": "article", "pub_date": "2005-07-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "In recent years, many anticonvulsant drugs have been widely prescribed not only for seizure disorders, but for various kinds of chronic pain and for several different psychiatric illnesses, even though few have been approved by the Food and Drug Administration for those purposes. Now researchers are reporting a case of brain swelling, or cerebral edema, after abrupt withdrawal from pregabalin (Lyrica), a new antiepileptic drug that will be available this fall. The report appears online and in the August issue of Annals of Neurology.", "headline": {"main": "Case Raises New Concern Over Withdrawal of Drugs"}, "abstract": null, "print_page": "7", "word_count": 637, "_id": "4fd260f38eb7c8105d811622", "snippet": "Researchers are reporting a case of brain swelling after abrupt withdrawal from a new antiepileptic drug that will be available this fall.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/19/health/policy/19drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "EPILEPSY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2005-07-19T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 12, "offset": 10, "time": 36}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}